Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.46% is 19% above its 5-year average of 11.29%, near the high end of its 5-year range (8.25%–14.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.13% above its 12-month average of 10.76%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
10.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
9.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
11.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
12.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
12.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.13%
CURRENT VS 3Y AVG
+40.36%
CURRENT VS 5Y AVG
+19.22%
CURRENT VS 10Y AVG
+12.13%
CURRENT VS 15Y AVG
+6.25%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+53.92%
vs the sector median at left
AbbVie Inc.
Market Cap
$439.40B
Return on Invested Capital (ROIC)
13.46%
TTM Avg
10.76%
3Y Avg
9.59%
5Y Avg
11.29%
Market Cap
$364.87B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
18.65%
3Y Avg
14.46%
5Y Avg
12.98%
Market Cap
$358.33B
Return on Invested Capital (ROIC)
9.19%
TTM Avg
10.28%
3Y Avg
12.20%
5Y Avg
12.63%
Market Cap
$340.66B
Return on Invested Capital (ROIC)
19.71%
TTM Avg
16.50%
3Y Avg
18.66%
5Y Avg
20.03%
Market Cap
$244.46B
Return on Invested Capital (ROIC)
12.83%
TTM Avg
11.72%
3Y Avg
9.44%
5Y Avg
7.92%
Market Cap
$644.65B
Return on Invested Capital (ROIC)
13.89%
TTM Avg
13.73%
3Y Avg
14.47%
5Y Avg
14.13%
Market Cap
$224.97B
Return on Invested Capital (ROIC)
7.44%
TTM Avg
7.81%
3Y Avg
8.16%
5Y Avg
9.11%
Market Cap
$210.69B
Return on Invested Capital (ROIC)
14.22%
TTM Avg
11.04%
3Y Avg
11.80%
5Y Avg
12.80%
Market Cap
$198.67B
Return on Invested Capital (ROIC)
30.21%
TTM Avg
34.36%
3Y Avg
43.28%
5Y Avg
43.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $439.40B | 13.46% | 10.76% | 9.59% | 11.29% |
| Merck & Co., Inc. (MRK)vs › | $364.87B | 5.80% | 18.65% | 14.46% | 12.98% |
| UnitedHealth Group Incorporated (UNH)vs › | $358.33B | 9.19% | 10.28% | 12.20% | 12.63% |
| Roche Holding AG (RHHBY)vs › | $340.66B | 19.71% | 16.50% | 18.66% | 20.03% |
| AstraZeneca PLC (AZN)vs › | $244.46B | 12.83% | 11.72% | 9.44% | 7.92% |
| Johnson & Johnson (JNJ)vs › | $644.65B | 13.89% | 13.73% | 14.47% | 14.13% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $224.97B | 7.44% | 7.81% | 8.16% | 9.11% |
| Amgen Inc. (AMGN)vs › | $210.69B | 14.22% | 11.04% | 11.80% | 12.80% |
| Novo Nordisk A/S (NVO)vs › | $198.67B | 30.21% | 34.36% | 43.28% | 43.42% |
| Abbott Laboratories (ABT)vs › | $182.80B | 6.07% | 9.16% | 9.70% | 9.86% |
ROIC
13.5%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 13.46% |
| 2026-03-31 | 10.29% |
| 2025-12-31 | 10.57% |
| 2025-09-30 | 9.02% |
| 2025-06-30 | 10.45% |
| 2025-03-31 | 9.58% |
| 2024-12-31 | 8.85% |
| 2024-09-30 | 8.73% |
| 2024-06-30 | 8.25% |
| 2024-03-31 | 8.67% |
| 2023-12-31 | 9.56% |
| 2023-09-30 | 11.52% |
| 2023-06-30 | 13.35% |
| 2023-03-31 | 12.40% |
| 2022-12-31 | 14.02% |
| 2022-09-30 | 13.63% |
| 2022-06-30 | 12.96% |
| 2022-03-31 | 13.66% |
| 2021-12-31 | 12.85% |
| 2021-09-30 | 13.07% |
| 2021-06-30 | 12.23% |
| 2021-03-31 | 9.13% |
| 2020-12-31 | 8.70% |
| 2020-09-30 | 8.22% |
| 2020-06-30 | 7.80% |
| 2020-03-31 | 16.25% |
| 2019-12-31 | 15.71% |
| 2019-09-30 | 13.95% |
| 2019-06-30 | 15.55% |
| 2019-03-31 | 14.44% |
| 2018-12-31 | 13.46% |
| 2018-09-30 | 16.73% |
| 2018-06-30 | 15.87% |
| 2018-03-31 | 12.96% |
| 2017-12-31 | 10.84% |
| 2017-09-30 | 13.23% |
| 2017-06-30 | 13.17% |
| 2017-03-31 | 12.80% |
| 2016-12-31 | 12.49% |
| 2016-09-30 | 12.36% |
| 2016-06-30 | 11.39% |
| 2016-03-31 | 13.93% |
| 2015-12-31 | 13.09% |
| 2015-09-30 | 8.19% |
| 2015-06-30 | 6.70% |
| 2015-03-31 | 13.56% |
| 2014-12-31 | 12.42% |
| 2014-09-30 | 18.55% |
| 2014-06-30 | 19.22% |
| 2014-03-31 | 19.57% |
| 2013-12-31 | 19.27% |
| 2013-09-30 | 22.09% |
| 2013-06-30 | 24.98% |
| 2013-03-31 | 26.52% |
| 2012-12-31 | 25.19% |
| 2012-09-30 | 28.21% |
| 2012-06-30 | 25.76% |
| 2012-03-31 | 26.43% |
| 2011-12-31 | 24.84% |
